Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Detection method for pharmaceutical composition for treating viral hepatitis

A technology of viral hepatitis and detection method, which is applied in the field of detection of pharmaceutical compositions for the treatment of viral hepatitis, and can solve problems such as drug resistance, addiction, and obvious side effects

Active Publication Date: 2015-01-07
BEIJING ASIA EAST BIO PHARMA CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the drugs currently used clinically for the treatment of viral hepatitis have certain curative effects, they have defects such as easy to cause drug resistance, addiction, and obvious side effects in the body to varying degrees.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Detection method for pharmaceutical composition for treating viral hepatitis
  • Detection method for pharmaceutical composition for treating viral hepatitis
  • Detection method for pharmaceutical composition for treating viral hepatitis

Examples

Experimental program
Comparison scheme
Effect test

experiment example 1

[0037] Experimental Example 1: Pharmacodynamic test of the drug group on liver protection, enzyme reduction, choleretic, jaundice reduction, phagocytosis and clearance

[0038] Drug group I: get the pharmaceutical composition mixture prepared in Example 2 of the present invention

[0039] Drug group II: take the pharmaceutical composition mixture prepared in Example 13 of the present invention

[0040] Control group: commercially available Qingre Shugan mixture.

[0041] one. Hepatoprotective and enzyme-lowering effect

[0042] 1. Protective effect on acute liver injury

[0043] Take 84 Kunming mice, weighing 18-20g, half male and half male, and randomly divide them into 7 groups. The first group: the normal control group, fed with the same amount of drinking water every day; the second group: the model group, fed with the same amount of drinking water every day; equivalent to 9.32 g of crude drug) / kg body weight per day; the fourth group: drug group II, orally administer...

experiment example 2

[0066] Experimental Example 2 Excipient screening experiment

[0067] Optimization of Inclusion Process Conditions of Volatile Oil β-Cyclodextrin

[0068]Since the volatile oil is easy to lose, if the volatile oil is directly added, left for a long time or slightly heated, the volatile oil will be lost, thereby reducing the content and affecting the curative effect of the drug. In order to solve this problem, the method of β-cyclodextrin inclusion was adopted, and the conditions of inclusion were optimized by orthogonal experiment.

[0069] See the accompanying drawings for the experimental procedure.

[0070] Inclusion by saturated aqueous solution method: Weigh a certain amount of β-cyclodextrin, add appropriate amount of distilled water, and heat it in a water bath at 70°C to make a 5% aqueous solution of β-cyclodextrin, at different temperatures (20°C, 40°C, 60°C) stirring at a speed of 2500 rpm, adding a certain amount of volatile oil, fully stirring for a certain perio...

experiment example 3

[0080] Experimental example 3 Identification test of capillary

[0081] Preparation of Blank Samples According to the ratio of herb taste and dosage of the medicine group of the present invention, a group of medicines not containing capillary root, white peony root, angelica sinensis, salvia miltiorrhiza and Polygonum cuspidatum were prepared respectively, and blank preparations were made according to the preparation process.

[0082] Preparation of blank solution Take the daily dose of blank sample 14 / 1000 of the pharmaceutical composition preparation capillary, add 20ml of water to dissolve, extract 2 times with ethyl acetate, 30ml for the first time, 20ml for the second time, and combine the ethyl acetate solution , evaporated to dryness in a water bath, and the residue was dissolved by adding 1ml of ethyl acetate as a blank solution.

[0083] Preparation of the sample solution Take the same amount of samples of the drug group and substance, and prepare the sample solution ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a detection method for a pharmaceutical composition for treating viral hepatitis. The pharmaceutical comprises bulk drugs of oriental wormwood, Poria cocos, radix curcumae, Sculellaria barbata, Pogostemon cablin, patchouli, bighead atractylodes rhizome and Polygonum cuspidatum. The detection method for the traditional Chinese medicine composition provided by the invention is acquired through screening of massive concrete creative tests; screening on sample treatment method and selection of a developing solvent in the identification method realize good specificity of the identification; besides, the method is economical and applicable, has rapid results, and can be applied to different thin-layer plates. In a content determination method, screening on treatment method for samples and test products and selection on the developing solvent enable the content determination method to effectively control the quality of the products. In addition, product determined by the method shows more stable drug effect performance than the products determined by other methods.

Description

[0001] The present invention is a divisional application, and the original application number is 200710119920.5 , the filing date of the original case is August 3, 2007 , the original name of the case is A kind of pharmaceutical composition and quality control method for treating viral hepatitis . field of invention [0002] The invention relates to a pharmaceutical composition, a preparation method and a quality control method, in particular to a pharmaceutical composition for treating viral hepatitis, a preparation method and a quality control method. Background technique [0003] Viral hepatitis is a common infectious disease caused by a variety of hepatitis viruses. It has the characteristics of strong infectivity, complex transmission routes, wide epidemic range, and high incidence rate. Clinically, the main manifestations are fatigue, loss of appetite, nausea, vomiting, hepatomegaly and liver function damage. Some patients may have jaundice and fever. Some patie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N30/02G01N30/36G01N30/90A61K36/9066A61P1/16A61P31/14A61P31/20
Inventor 付立家付建家
Owner BEIJING ASIA EAST BIO PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com